Status:
UNKNOWN
Rib Fracture Cryoanalgesia
Lead Sponsor:
Methodist Health System
Collaborating Sponsors:
Pacira Pharmaceuticals, Inc
Conditions:
Pain Management Improvement
Eligibility:
All Genders
18-75 years
Brief Summary
Rib fractures lead to poor patient outcomes and even death 3. Data suggests effective pain management is crucial to obtain favorable outcomes 4, 5Current outpatient treatment modalities are limited to...
Detailed Description
Methodist Dallas Medical Center MDMC is an urban Level I Trauma Center that manages over 200 rib fracture cases annually. MDMC has a history of developing and using innovative analgesia techniques aim...
Eligibility Criteria
Inclusion
- 18 years of age Acute pain attributed to rib fracture(s) Able to obtain consent
Exclusion
- \<18 years of age Pregnant Incarcerated Confounding injuries or significant pain attributed to secondary injury Patients with any of the following: cryoglobulinemia; paroxysmal cold hemoglobinuria; cold urticarial; Raynaud's disease; open and/or infected wounds at or near the treatment site
Key Trial Info
Start Date :
June 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 5 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06093776
Start Date
June 5 2023
End Date
June 5 2025
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203